POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Pfizer CEO says third COVID-19 vaccine dose likely needed within 12 months

Christian Fernsby |
Pfizer Chief Executive Officer Albert Bourla said people will likely need a third dose of the Pfizer/BioNTech COVID-19 vaccine within 12 months of getting fully vaccinated, according to a CNBC report on Thursday.

Article continues below




Bourla said it is possible people will need to get vaccinated against the coronavirus annually.

"We need to see what would be the sequence, and for how often we need to do that, that remains to be seen," he told CNBC. "A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual revaccination, but all of that needs to be confirmed. And again, the variants will play a key role," he said.

Pfizer said earlier this month that its COVID-19 vaccine was more than 91 percent effective at protecting against the coronavirus, and more than 95 percent effective against severe disease up to six months after the second dose.

The data was based on more than 12,000 vaccinated participants. Researchers are still working on how long protection against the virus lasts once individuals has been fully vaccinated.


What to read next

World-first COVID-19 alternating dose vaccine study launches in UK
Pfizer says kids 12 to 15 respond great to vaccine
Chile approves Pfizer coronavirus vaccine for emergency use